In Silico Clinical Trials Market Size & Analysis | Report 2021, 2028

<h2 class='h5'>In Silico Trials: Computational Modelling and Simulation for Medical Product Innovation and Regulatory Clearance Market Report Scope</h2><div class='gt-ig-table mt-4 row'><div class='col-12 col-lg-8 mx-auto text-lg-start'><table class='shadow table table-bordered table-striped'><tr><th>Report Attribute<th>Details<tr><td>Market size in 2021<td>US$ 2.96 Billion <tr><td>Market Size by 2028<td>US$ 6.83 Billion <tr><td>Global CAGR (2021 - 2028)<td>12.7%<tr><td>Historical Data<td>2019-2020<tr><td>Forecast period<td>2022-2028<tr><td>Segments Covered<td><span>By Organization Size </span><ul><li>Small & Medium Organizations</li><li> Large Organizations</li></ul><span>By Offerings </span><ul><li>Products</li><li> Platforms</li><li> Services</li></ul><span>By Application </span><ul><li>Product Design & Discovery</li><li> Product Development</li><li> Pre-Clinical Targeting</li><li> Assessment of Drugs & Other Biomedical Products</li></ul><span>By Clinical Indication </span><ul><li>Cardiovascular Diseases</li><li> Neurodegenerative Diseases</li><li> Oncology</li><li> Rare Diseases</li><li> Metabolic Diseases</li><li> Immune Based Diseases</li><li> Infectious Diseases</li></ul></tr><tr><td>Regions and Countries Covered<td><span>North America </span><ul><li>US</li><li> Canada</li><li> Mexico </li></ul><span>Europe </span><ul><li>UK</li><li> Germany</li><li> France</li><li> Russia</li><li> Italy</li><li> Rest of Europe </li></ul><span>Asia-Pacific </span><ul><li>China</li><li> India</li><li> Japan</li><li> Australia</li><li> Rest of Asia-Pacific </li></ul><span>South and Central America </span><ul><li>Brazil</li><li> Argentina</li><li> Rest of South and Central America </li></ul><span>Middle East and Africa </span><ul><li>South Africa</li><li> Saudi Arabia</li><li> UAE</li><li> Rest of Middle East and Africa</li></ul></tr><tr><td>Market leaders and key company profiles<td><li></li><li> InSilico Trials Technologies</li><li> Feops</li><li> CADFEM Medical GmbH</li><li> Dassault Systèmes</li><li> Virtonomy GmbH</li><li> Certara Inc.</li><li> Computational Life</li><li> NOVA</li><li> TwInsight Medical</li></tr></table></div></div>

<h2 class='h5'>虚拟实验：医学产品创新与监管批准市场计算建模与仿真报告概览</h2><div class='gt-ig-table mt-4 row'><div class='col-12 col-lg-8 mx-auto text-lg-start'><table class='shadow table table-bordered table-striped'><tr><th>报告属性<th>详细信息<tr><td>2021年市场规模<td>29.6亿美元 <tr><td>2028年市场规模<td>68.3亿美元 <tr><td>全球复合年增长率（2021-2028）<td>12.7%<tr><td>历史数据<td>2019-2020年 <tr><td>预测期<td>2022-2028年 <tr><td>涵盖的细分市场<td><span>按组织规模 </span><ul><li>小型和中型组织</li><li>大型组织</li></ul><span>按产品类型 </span><ul><li>产品</li><li>平台</li><li>服务</li></ul><span>按应用 </span><ul><li>产品设计与发现</li><li>产品开发</li><li>临床前靶向</li><li>药物及其他生物医药产品的评估</li></ul><span>按临床指征 </span><ul><li>心血管疾病</li><li>神经退行性疾病</li><li>肿瘤学</li><li>罕见病</li><li>代谢性疾病</li><li>基于免疫的疾病</li><li>传染病</li></ul></tr><tr><td>涵盖的区域和国家<td><span>北美 </span><ul><li>美国</li><li>加拿大</li><li>墨西哥</li></ul><span>欧洲 </span><ul><li>英国</li><li>德国</li><li>法国</li><li>俄罗斯</li><li>意大利</li><li>欧洲其他地区</li></ul><span>亚太地区 </span><ul><li>中国</li><li>印度</li><li>日本</li><li>澳大利亚</li><li>亚太地区其他地区</li></ul><span>南美和中美洲 </span><ul><li>巴西</li><li>阿根廷</li><li>南美和中美洲其他地区</li></ul><span>中东和非洲 </span><ul><li>南非</li><li>沙特阿拉伯</li><li>阿联酋</li><li>中东和非洲其他地区</li></ul></tr><tr><td>市场领先企业和关键公司简介<td><li></li><li>InSilico Trials Technologies</li><li>Feops</li><li>CADFEM Medical GmbH</li><li>Dassault Systèmes</li><li>Virtonomy GmbH</li><li>Certara Inc.</li><li>Computational Life</li><li>NOVA</li><li>TwInsight Medical</li></tr></table></div></div>